Container

Maersk secures three-year contract with Novo Nordisk to ship insulin

A.P. Møller-Maersk enters a three-year contract with Novo Nordisk to handle the pharmaceutical company's insulin transports. Maersk will be shipping nearly half of Novo's insulin production, according to Børsen.
Photo: Thomas Borberg/Politiken/Ritzau Scanpix
Photo: Thomas Borberg/Politiken/Ritzau Scanpix
by SØREN PICO

Maersk and Novo Nordisk now join forces with a multiple-year contract, in which the Danish shipping company will be in charge of shipping a significant share of Novo's insulin.

Already a subscriber?Log in here

Read the whole article

Get access for 7 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
    • Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
    Must contain at least 2 characters
    Must contain at least 2 characters

    Get full access for you and your coworkers

    Start a free company trial today

    Share article

    Related articles

    Sign up for our newsletter

    Stay ahead of development by receiving our newsletter on the latest sector knowledge.

    Newsletter terms

    Front page now

    Further reading

    Jobs